We don’t look for racism
It’s there
It’s everywhere
No matter how or what…
It’s still here breathin
You can’t deny its smoky lungs….
You said to us
Shut up…
But we ain’t listenin
We chose not to deal
We stand our ground
We talk back
And we will never apologize…
Cos you’re always in the wrong
You’re part of the issue…
You plays in the role of your faults…
You act like victims when you make
Your choices to oppress others who
Doesn’t look like you….
You can scream
Through tantrums
Ask your token house negro to put us
In our place
We will ignore the shit out of you….
We don’t look for it
We don’t search
We feel it in a way
We encourage our people to
Defend themselves
To the the right thing
And not standin there takin racial insults
Nor threats….
White man
His race
Shouldn’t scare us
Not other races either….
It’s okay to be violent if necessary
Cos they wanna slaughter us as much as they can….
I mean we’re still Exhalin our own genocides that white supremacy
Created….
We know it’s there
An elephant in the room
It doesn’t go away….
You don’t wanna dismantle it,
Yet it’s crumblin between your feet
You see more black people fightin back
Fiercely behind the scenes…
They will always outthink you
It’s why they never show themselves on
Social media cos they’re actually doin the work….
We know you, enemy
We know you work too hard to try to
Fuck our rhythms…try to disrupt our
Melanated flow….
You did every tactic to kill an African leader…
Yet he outmaneuvered you…
Ya we know you’re frustrated….
We know you want him vanish off this earth…
He’s intelligent and you hate that….
Oh enemy, you need to get over yourself
You need to accept that you’re a minority on this planet….
Karma said soon enough you gotta let that power go….
Nobody will listen to your every fork tongue anymore…
I’m not here to rub it in, I’m just a reminder…
Another message you don’t even bother to pay attention to…
You only hate a black woman in a wheelchair who told you so….
✊🏿💯©️ Kai C. 4-9-25
https://www.facebook.com/share..../r/18n1yEqu7y/?mibex
Cultured Meat Market Size, Demand, Analytical Overview, Comprehensive Analysis, Segmentation, Competitive Landscape 2035
Meat is described as a muscle tissue derived from an animal source that imparts several health benefits when included in the diet. It acts as an important source of macronutrients and micronutrients such as proteins, fats, carbohydrates and vitamins that provide with the ability to build and repair worn out tissues as well as fulfill the energy requirements of the body.
The global cultured meat market size is estimated to be worth USD 0.2 billion in 2024 and is expected to be worth USD 229 billion by 2050, growing at a CAGR of 30.8% during the forecast period, till 2050.
Given its several advantages, the demand for meat is increasing extensively, which has led to a three-fold increase in industrial meat production. In this context, globally, over 350 million tons of meat is being produced annually. Despite being able to cater to the ever increasing demand, the process of meat production has led to several harmful impacts on the environment including water scarcity, overburden on the land resources and an increase in the pollution levels associated with high levels of greenhouse gas emission and the increased carbon content. This has prompted the industrial stakeholders to discover and implement novel approaches of meat production, such that it suffices the basic need of human consumption in a sustainable and eco-friendly way. Cultured meat production is one such process that involves direct isolation of cells from an animal source, cell culturing and cell structuring for the in-vitro development of meat.
Further, conventional meat production is a process that involves the use of traditional farming practices such as raising animals and subsequently, slaughtering them in order to derive meat products. Although this is the process that has sufficed the global meat demand for years, it has been observed that the process is associated with several drawbacks. On the other hand, cultured meat production is a relatively efficient and sustainable approach, which is designed to maintain a balance between demand and supply chain of meat industry while mitigating the environmental and sustainability concerns associated with the traditional methods of meat production. This can be validated through estimates generated by The United Nation’s Food and Agricultural Organization, which suggest that in-vitro cultured meat demonstrates a 96% reduction in the greenhouse gas emission, as compared to conventionally produced meat.
It is worth mentioning that the cultured meat industry is presently dominated by the presence of small firms (72%). This can be attributed to the fact that this domain is still in the early stages of development, thus presenting opportunities for stakeholders to explore in the coming future. Most of the players engaged in this domain offer minced form of cultured meat products. This can be attributed to its enhanced nutrition profile and the ability to be restructured. It is also worth mentioning that several commercialized products have been launched in collaboration with restaurants. Further, considering the active engagement of industry players in this domain, the market for cultured meat is likely to grow in the foreseen future.
Research Methodology
Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Cultured Meat Market.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To get sample report visit@
https://www.rootsanalysis.com/....reports/cultured-mea
Continuous Manufacturing Market Share, Global Industry Size, Trends, Technology, and Analysis by 2035
For decades, pharmaceutical companies have been using batch processing method for drug manufacturing, wherein a specific quantity of a drug is produced through multiple sequential steps.
The global continuous manufacturing market size is estimated to be worth USD 2,080 million in 2023 and anticipated to grow at a CAGR of 6.4% during the forecast period.
Presently, close to 60 manufacturers have adopted continuous manufacturing for single or multiple unit operations. Various types of biologics, including antibodies, enzymes, proteins / peptides, vaccines and viral vectors can be synthesized utilizing continuous manufacturing technique. It is worth noting that close to 75% of the continuous biologic manufacturers offer contract manufacturing services for continuous manufacturing of the above mentioned biologics.
Close to 700 patents related to continuous manufacturing have been filed by / granted to various organizations in order to protect the intellectual property. The increasing interest of industry and non-industry stakeholders in continuous manufacturing of small molecules and biologics has led to the expansion of intellectual capital in this domain. There has been a steady increase in the number of patents filed / granted, which indicates continuous research in this domain. This can be attributed to the several advantages offered by continuous manufacturing over conventional batch manufacturing, including the need for smaller facility space, reduced cost of production, low risk of contamination and continuous monitoring utilizing process analytical technology (PAT).
Majority of the patents filed in this domain are patent applications (67%), followed by those which have been granted approval (23%). Further, majority of the patents (82%) were filed / granted by industry players, followed by non-industry players. Moreover, despite the large number of patents that have been filed recently (and hence having a long remaining patent life), only 1% of the total patents have the highest relative valuation.
The continuous biologics manufacturing market is likely to grow at a cagr of ~9% over the next decade; driven by revenues generated from continuous upstream bioprocessing. As per the base case forecast scenario, the biologic continuous manufacturing market is estimated to grow at an annualized rate of ~9%, during the period 2023 to 2035. This opportunity will likely be well distributed across purpose of manufacturing, type of product manufactured, stage of bioprocessing, scale of operation, company size and key geographical regions.
It is worth mentioning that according to our projections, the markets in Europe are likely to capture majority (40%) of the overall biologic continuous manufacturing market, and this trend is unlikely to change in the future, as well. It is worth highlighting that the market in Asia-Pacific is expected to grow at a higher CAGR as compared to other regions in the coming years.
Research Methodology
Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Continuous Manufacturing Market.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To get sample report visit@
https://www.rootsanalysis.com/....reports/continuous-m